Fundraising FoxAberdare Ventures
Venture capitalSan Francisco · Seed–Series A · 1 people tracked
Also known as ABERDARE MANAGEMENT COMPANY, LLC
Find your way into Aberdare Ventures
Sign up to see every warm intro you have to Aberdare Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aberdare Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Aberdare Ventures focuses exclusively on healthcare, backing transformational companies that enable more efficient, less costly, and smarter healthcare delivery.
Source: firm website, verified Oct 3, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 9 of 12 portfolio companiesHealthtech ×8Digital Health ×7AI & Machine Learning ×3Biotech ×2Medical Devices ×2Data & Infrastructure ×1InsurTech ×1Mental Health ×1
HQs:United States×9
Investments · 12 tracked
founders shown can be your intro pathBy year:2018 · 12015 · 12014 · 22012 · 12007 · 12006 · 12002 · 18 dated
Cyclerion is a biopharmaceutical company developing therapeutics for neuropsychiatric diseases, with a lead candidate (CYC-126) for treatment-resistant depression that pairs anesthetic agents with a personalized biofeedback-driven device.
BiotechDigital HealthMental HealthCambridge, US
William Huyett(Executive Officer)Mark G. Currie(Executive Officer)inRegina M. Graul(President and Chief Executive Officer)inOle Isacson(Director)Stephanie Lovell(Director)Marsha Fanucci(Director)
Co-investorsPappas CapitalEcoR1 CapitalInvusPolaris Partners
Cricket Health provides value-based kidney care, using a holistic approach to treat people with chronic kidney disease and related cardiovascular conditions.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Arvind Rajan(Executive Officer, Director)inDr. Carney Taylor(Chief Medical Officer)Dr. Terry Ketchersid(Senior Vice President, Medical Office)Dr. Julie Dominguez(Vice President, Medical Office)
BoardVincent Kim(Director)
Co-investorsLifeforce CapitalNext Play VenturesNFXWormhole CapitalBoxGroupFirst Round Capital+5 more
Gravie provides health benefits products for small and midsize businesses, including its flagship Comfort level-funded health plan with zero-cost coverage of common services, as well as traditional copay/HSA plans and ICHRA administration.
Digital HealthHealthtechInsurTechMinneapolis, US
Abir Sen(Founder)Marek Ciolko(Founder)Marlon Cush(Executive Officer)inDan Schabold(Executive Officer)inSteve Wolin(CEO)inJill Prevost(Executive Officer, Promoter)in
Co-investorsBrightstone Venture CapitalFirstMark CapitalGeneral AtlanticK2 HealthVenturesNat TurnerWormhole Capital+2 more
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)
BoardMarc Singer(Director)in
Co-investorsBraemar Energy VenturesMitsui Global InvestmentOUP (Osage University Partners)Windham Capital PartnersNorth Bridge Venture Partners & Growth Equity
Nevro develops spinal cord stimulation systems for pain management, offering the Senza Trial Stimulator with high-frequency therapy options and wireless capability for patient trials and treatment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesRedwood City, US
Co-investorsBay City CapitalNew Enterprise Associates (NEA)Accuitive Medical Ventures
BrainHQ is an online brain-training program built on neuroplasticity research, offering adaptive exercises that target attention, brain speed, memory, people skills, navigation, and intelligence.
Digital HealthHealthtechWellness & Fitness
Michael Merzenich(Lead Neuroscientist)
RxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechPortland, US
Josh Benner(Co-Founder & CEO)inLisa Jurinka(SVP, General Counsel)inNiteesh Choudhry(SVP, Chief Medical and Science Officer)inAmie Joyce(SVP, Head of Technology Operations)inPatrick Baker(SVP, General Manager at Mosaic Pharmacy Service)Jessica Frank(SVP, Client Success)in
Co-investorsPrimus CapitalFirst Trust Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Autonomic TechnologiesAnacor PharmaceuticalCervel NeurotechConatus PharmaceuticalsSonitus Medical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
1 IPOs · 1 acquisitionsCyclerion TherapeuticsNASDAQ: CYCNMC10acq. by Medidata
Portfolio news
latest coverage across their companies
Gravie · trysignalbase.com · Aug 3, 2026
RxAnte · finsmes.com · Jan 13, 2026
Fund performance · per public LP disclosures · 2
as of Sep 2021| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Aberdare Ventures IV, LPLPs: California Public Employees' Retirement System | 2008 | — | -0.2% | 0.99x | 0.46x |
| Aberdare Ventures III, LPLPs: California Public Employees' Retirement System | 2005 | — | 2.7% | 1.17x | 0.98x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Jul 2013
Disclosed stake · filed Apr 2012
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Aberdare Ventures made?
- Aberdare Ventures has 12 tracked investments, 2 of which have exited.
- What stage does Aberdare Ventures invest at?
- Aberdare Ventures invests at the Seed, Series A stages.
- What is Aberdare Ventures's typical check size?
- Aberdare Ventures typically writes checks of $500K – $15M.
- What sectors does Aberdare Ventures focus on?
- Aberdare Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Aberdare Ventures located?
- Aberdare Ventures is headquartered in San Francisco, US.
- Does Aberdare Ventures lead rounds?
- Aberdare Ventures typically participates in rounds rather than leading them.
Images
Co-investors · 7
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Breakthrough Energy, founded by Bill Gates, backs innovators developing affordable, reliable, and clean energy technologies, investing across manufacturing, electricity, agriculture, transportation, and buildings.
MassMutual Ventures is the venture capital arm of Massachusetts Mutual Life Insurance Company, investing in technology companies and supporting their growth with capital, connections, and expertise.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Advent Life Sciences is a trans-Atlantic venture capital firm investing in early and mid-stage life sciences companies across the UK, Europe and the USA.
Merck Global Health Innovation Fund (MGHIF) is the corporate venture arm of Merck & Co., investing in digital health and data science companies that support and optimize biopharmaceutical operations to improve patient care.
Acorn Bioventures invests across multiple stages in small-cap public and private biotechnology companies developing novel innovative medicines. The firm offers flexible capital structures including seed financing, cross-over financings, IPOs, registered direct offerings, PIPEs, and open market purchases.
Firms observed investing alongside Aberdare Ventures, from public investor directories. Shared companies are the overlap with Aberdare Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.